dilactide has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baruah, M; Garnaik, B; Giram, P; Khandwekar, A; Koratkar, S; Sharma, N; Shitole, AA | 1 |
| Du, L; Jin, Y; Li, X; Mei, X; Wang, C; Zhang, F | 1 |
2 other study(ies) available for dilactide and Cancer of Prostate
| Article | Year |
|---|---|
LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Dioxanes; Docetaxel; Drug Carriers; Gonadotropin-Releasing Hormone; Humans; Male; Nanocapsules; Nanoparticles; Polyethylene Glycols; Prostatic Neoplasms; Quercetin | 2020 |
In-vitro/in-vivo studies of the biodegradable poly-(D,L-lactide-co-glycolide) microspheres of a novel luteinizing hormone-releasing hormone antagonist for prostate cancer treatment.
Topics: Animals; Antineoplastic Agents; Dioxanes; Drug Delivery Systems; Gonadotropin-Releasing Hormone; Humans; Lactic Acid; Male; Microspheres; Oligopeptides; Orchiectomy; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Prostate; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Receptors, LHRH; Testis; Testosterone | 2011 |